Barrio J R, MacDonald N S, Robinson G D, Najafi A, Cook J S, Kuhl D E
J Nucl Med. 1981 Apr;22(4):372-5.
A routine production system for 2-deoxy-2-[18F]fluoro-D-glucose (2-18FDG) for medical use is presented. The method involves the preparation of F-18-labeled F2 by the 20Ne(d, alpha) 18F reaction, subsequent fluorination of 3,4,6-tri-o-acetyl-D-glucal, purification, and hydrolysis of the appropriate diastereoisomer to obtain 2-18FDG. These operations are performed using a completely remote, semiautomatic system. There have been no failures in more than 220 consecutive production runs. Currently, two preparations per day of 15-25 mCi of 2-18FDG are routinely performed, with a radiochemical purity, measured by TLC, in excess of 95% and with less than 1 mR radiation exposure to the chemist. Reaction conditions, operational variables, and systems are described in detail.
介绍了一种用于医用2-脱氧-2-[18F]氟-D-葡萄糖(2-18FDG)的常规生产系统。该方法包括通过20Ne(d,α)18F反应制备F-18标记的F2,随后对3,4,6-三-O-乙酰基-D-葡糖醛进行氟化、纯化,并水解适当的非对映异构体以获得2-18FDG。这些操作使用完全远程的半自动系统进行。在连续220多次生产运行中没有出现故障。目前,每天常规制备15 - 25 mCi的2-18FDG两次,通过薄层层析法测量,其放射化学纯度超过95%,并且化学家所受辐射暴露小于1 mR。详细描述了反应条件、操作变量和系统。